ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 258 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $213,149,000 | +70.3% | 2,293,409 | +9.1% | 0.01% | +42.9% |
| Q3 2021 | $125,174,000 | -1.8% | 2,102,000 | +12.4% | 0.01% | 0.0% |
| Q2 2021 | $127,531,000 | +5.1% | 1,869,962 | +6.9% | 0.01% | 0.0% |
| Q1 2021 | $121,349,000 | -23.7% | 1,748,792 | -15.5% | 0.01% | -30.0% |
| Q4 2020 | $159,086,000 | +9.9% | 2,070,623 | +7.0% | 0.01% | 0.0% |
| Q3 2020 | $144,788,000 | +10.8% | 1,935,924 | -6.7% | 0.01% | 0.0% |
| Q2 2020 | $130,678,000 | +64.7% | 2,075,906 | +9.9% | 0.01% | +42.9% |
| Q1 2020 | $79,322,000 | -5.3% | 1,888,611 | +2.4% | 0.01% | +16.7% |
| Q4 2019 | $83,786,000 | -9.2% | 1,844,701 | -8.5% | 0.01% | -14.3% |
| Q3 2019 | $92,277,000 | -10.2% | 2,016,099 | +15.0% | 0.01% | -12.5% |
| Q2 2019 | $102,768,000 | +17.6% | 1,752,817 | -10.1% | 0.01% | +14.3% |
| Q1 2019 | $87,363,000 | +12.2% | 1,948,764 | -2.5% | 0.01% | 0.0% |
| Q4 2018 | $77,860,000 | -29.2% | 1,998,980 | -16.4% | 0.01% | -12.5% |
| Q3 2018 | $109,971,000 | +7.0% | 2,389,710 | +1.4% | 0.01% | -11.1% |
| Q2 2018 | $102,790,000 | +29.6% | 2,357,529 | +17.4% | 0.01% | +28.6% |
| Q1 2018 | $79,309,000 | +64.4% | 2,007,870 | +41.4% | 0.01% | +75.0% |
| Q4 2017 | $48,240,000 | +9.5% | 1,420,199 | -17.8% | 0.00% | 0.0% |
| Q3 2017 | $44,059,000 | +212.0% | 1,727,818 | +106.5% | 0.00% | +300.0% |
| Q2 2017 | $14,122,000 | – | 836,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |